ArticleVaccines2026

A Precision-Engineered DC-Targeting mRNA-LNP Neoantigen Vaccine Elicits Stronger T Cell Responses and Exhibits Superior Tumor Control.

Qi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.